Signor Biotech was founded by a research team from Tsinghua University, combining cutting-edge medical and engineering technologies to highly restore the physiological state of maternal tissues and form "micro organs" (i.e. organoids) composed of multiple cell types. The team has completed the establishment of various human tissue and tumor organoid models. These in vitro organoid models use patient derived postoperative or puncture tissues, which undergo strict biological processing procedures for high-throughput preparation and precise cultivation of organoids. The organoids prepared by Signor can highly reproduce the original biological characteristics of the mother plant, making it an excellent model for patients to "substitute drugs".

    Enterprise official website: http://www.synorgbio.com/